MacroGenics, Inc.
MGNX
$4.11
-$0.21-4.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 388.50% | -83.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 388.50% | -83.70% | |||
| Cost of Revenue | 10.88% | -20.67% | |||
| Gross Profit | 78.95% | -887.18% | |||
| SG&A Expenses | -18.60% | 5.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.48% | -16.20% | |||
| Operating Income | 63.51% | -213.82% | |||
| Income Before Tax | -68.63% | -176.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -68.63% | -191.76% | |||
| Earnings from Discontinued Operations | 1,870.76% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 153.07% | -159.80% | |||
| EBIT | 63.51% | -213.82% | |||
| EBITDA | 63.77% | -249.08% | |||
| EPS Basic | 152.95% | -159.10% | |||
| Normalized Basic EPS | 59.22% | -175.80% | |||
| EPS Diluted | 152.10% | -159.10% | |||
| Normalized Diluted EPS | 59.22% | -175.80% | |||
| Average Basic Shares Outstanding | 0.23% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.23% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||